Status:

COMPLETED

Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)

Lead Sponsor:

Pfizer

Conditions:

Hospital-Acquired Pneumonia

Eligibility:

All Genders

18-90 years

Phase:

PHASE4

Brief Summary

This is a prospective, single arm, open-label, multi-center clinical study evaluating the effectiveness and safety of CAZ-AVI in participants with HAP (including VAP), who have initiated treatment wit...

Eligibility Criteria

Inclusion

  • Male or female participants ≥18 and ≤90 years of age.
  • Onset of symptoms ≥48 hours after admission or \<7 days after discharge from an inpatient acute or chronic care facility.
  • New or worsening infiltrate on chest X-ray obtained within 48 hours prior to screening.
  • Participants have systemic signs and respiratory signs or symptoms of HAP/VAP

Exclusion

  • Other medical or psychiatric condition may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study.
  • Participant is expected to require a treatment course for HAP longer than 14 days.
  • The total duration of antibiotic exposure for antibiotics whose administration begins in the 48 hours is longer than 24 hours.
  • Previous administration with an investigational drug within 30 days or 5 half lives preceding the first dose of study intervention used in this study (whichever is longer).
  • Acute Physiology and Chronic Health Evaluation (APACHE) II score \>30 or \<10 using the most recent available data.

Key Trial Info

Start Date :

May 21 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 4 2023

Estimated Enrollment :

235 Patients enrolled

Trial Details

Trial ID

NCT04774094

Start Date

May 21 2021

End Date

May 4 2023

Last Update

September 19 2024

Active Locations (56)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 14 (56 locations)

1

Fuyang People's Hospital

Fuyang, Anhui, China, 236000

2

Peking University Third Hospital

Beijing, Beijing Municipality, China, 100191

3

The First Affiliated Hospital of Fujian Medical University

Fuzhou, Fujian, China, 350005

4

Zhongshan Hospital Xiamen University

Xiamen, Fujian, China, 361004